Bellicum offloads cell therapy plant in switch to outsourced production
Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.
Archives for January 28, 2020
BioIVT in deal with upcyte on liver cells for in-vitro research
BioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte.